U.S. Manufacturing. COMPANY agrees that any LICENSED PRODUCTS used or sold in the United States will be manufactured substantially in the United States.
Appears in 5 contracts
Sources: Exclusive Patent License Agreement (Synlogic, Inc.), Exclusive Patent License Agreement (Bionik Laboratories Corp.), Exclusive Patent License Agreement (ExOne Co)
U.S. Manufacturing. COMPANY agrees that any LICENSED PRODUCTS used or sold in the United States will be manufactured substantially in the United StatesStates to the extent required by applicable laws and/or regulations.
Appears in 5 contracts
Sources: Exclusive Patent License Agreement (SQZ Biotechnologies Co), Exclusive Patent License Agreement (Selecta Biosciences Inc), Exclusive Patent License Agreement (Selecta Biosciences Inc)
U.S. Manufacturing. COMPANY agrees that any LICENSED PRODUCTS used or sold in the United States will be manufactured substantially in the United StatesStates unless all required waivers are obtained by COMPANY.
Appears in 2 contracts
Sources: Exclusive Patent License Agreement (A123 Systems, Inc.), Exclusive Patent License Agreement (A123 Systems Inc)
U.S. Manufacturing. COMPANY Company agrees that any LICENSED PRODUCTS Products or Processes used or sold in the United States will be manufactured substantially in the United StatesStates to the extent required by law.
Appears in 1 contract
Sources: Exclusive Patent License Agreement (Juniper Pharmaceuticals Inc)
U.S. Manufacturing. COMPANY agrees that that, to the extent it is commercially reasonable, any LICENSED PRODUCTS used or sold SOLD in the United States will be manufactured substantially in the United StatesStates .
Appears in 1 contract
Sources: Exclusive Patent License Agreement (Cardiomems Inc)
U.S. Manufacturing. COMPANY agrees that any LICENSED PRODUCTS used or sold in the United States will be manufactured substantially in the United StatesStates to the extent required by applicable laws.
Appears in 1 contract
Sources: Exclusive Patent License Agreement (Cerulean Pharma Inc.)